GEOVAX LABS, INC. Earnings Per Share (Basic)
GEOVAX LABS, INC. (GOVX) reported Earnings Per Share (Basic) of -$0.97 per share for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-17
- GEOVAX LABS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.97.
- GEOVAX LABS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$2.62.
- GEOVAX LABS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.09, a 88.71% decline year-over-year.
- GEOVAX LABS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.31.
- GEOVAX LABS, INC. earnings per share, basic for fiscal 2023 was -$14.29.
- GEOVAX LABS, INC. earnings per share, basic for fiscal 2022 was -$12.39.
- GEOVAX LABS, INC. earnings per share, basic for fiscal 2021 was -$3.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed | Earnings Per Share, Basic 126 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.97 S-1 · filed 2026-09-17 | -$2.94 S-1 · filed 2026-09-17 | $1.01 derived: net income ÷ weighted average shares · filed 2026-09-17 | $3.75 derived: net income ÷ weighted average shares · filed 2026-09-17 | |||||
| 2026-03-31 | -$2.62 10-Q · filed 2026-05-14 | $0.42 derived: net income ÷ weighted average shares · filed 2026-09-17 | $1.82 derived: net income ÷ weighted average shares · filed 2026-09-17 | $3.32 derived: net income ÷ weighted average shares · filed 2026-09-17 | |||||
| 2025-12-31 | $0.09 derived: net income ÷ weighted average shares · filed 2026-09-17 | $0.76 derived: net income ÷ weighted average shares · filed 2026-09-17 | $1.74 derived: net income ÷ weighted average shares · filed 2026-09-17 | -$22.40 S-1 · filed 2026-09-17 | |||||
| 2025-09-30 | -$0.31 10-Q · filed 2025-11-13 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-09-17 | -$0.97 10-Q · filed 2025-11-13 | -$9.12 derived: net income ÷ weighted average shares · filed 2026-09-17 | |||||
| 2025-06-30 | -$8.74 S-1 · filed 2026-09-17 | -$0.35 10-Q · filed 2025-07-28 | -$19.72 S-1 · filed 2026-09-17 | -$0.79 10-Q · filed 2025-07-28 | $6.21 derived: net income ÷ weighted average shares · filed 2026-09-17 | $35.74 derived: net income ÷ weighted average shares · filed 2026-09-17 | |||
| 2025-03-31 | -$11.20 10-Q · filed 2026-05-14 | -$0.45 10-Q · filed 2025-05-01 | $2.78 derived: net income ÷ weighted average shares · filed 2026-09-17 | $17.20 derived: net income ÷ weighted average shares · filed 2026-09-17 | $115.21 derived: net income ÷ weighted average shares · filed 2026-09-17 | ||||
| 2024-12-31 | $0.80 derived: net income ÷ weighted average shares · filed 2026-09-17 | $7.28 derived: net income ÷ weighted average shares · filed 2026-09-17 | $43.22 derived: net income ÷ weighted average shares · filed 2026-09-17 | -$120.46 S-1 · filed 2026-09-17 | -$4.82 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | -$0.91 10-Q · filed 2025-11-13 | -$2.43 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$4.52 10-Q · filed 2025-11-13 | -$7.32 derived: net income ÷ weighted average shares · filed 2026-05-18 | |||||
| 2024-06-30 | -$1.99 10-Q · filed 2025-07-28 | -$4.68 10-Q · filed 2025-07-28 | -$8.06 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$12.44 derived: net income ÷ weighted average shares · filed 2026-05-18 | |||||
| 2024-03-31 | -$2.47 10-Q · filed 2025-05-01 | -$6.18 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$10.72 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$14.47 derived: net income ÷ weighted average shares · filed 2026-05-18 | |||||
| 2023-12-31 | -$3.83 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$8.53 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$12.38 derived: net income ÷ weighted average shares · filed 2026-05-18 | -$14.29 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | -$4.75 10-Q · filed 2024-11-12 | -$0.32 10-Q · filed 2023-11-08 | -$8.60 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$10.42 10-Q · filed 2024-11-12 | -$0.69 10-Q · filed 2023-11-08 | $2.98 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2023-06-30 | -$3.79 10-Q · filed 2024-08-06 | -$0.22 10-Q · filed 2023-08-09 | -$5.66 10-Q · filed 2024-08-06 | -$0.38 10-Q · filed 2023-08-09 | $1.37 derived: net income ÷ weighted average shares · filed 2024-11-12 | $7.61 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2023-03-31 | -$2.30 10-Q · filed 2024-05-14 | -$0.15 10-Q · filed 2023-05-04 | $0.54 derived: net income ÷ weighted average shares · filed 2024-11-12 | $3.43 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$61.88 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2022-12-31 | $0.15 derived: net income ÷ weighted average shares · filed 2024-02-29 | $1.39 derived: net income ÷ weighted average shares · filed 2024-02-29 | $46.66 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$12.39 10-K · filed 2024-02-29 | -$0.83 10-K · filed 2023-03-23 | ||||
| 2022-09-30 | -$0.17 10-Q · filed 2023-11-08 | -$0.34 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.63 10-Q · filed 2023-11-08 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||||
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-09 | -$0.47 10-Q · filed 2023-08-09 | -$2.11 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.50 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||||
| 2022-03-31 | -$0.34 10-Q · filed 2023-05-04 | -$2.40 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.74 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.97 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||||
| 2021-12-31 | -$2.15 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$2.46 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$2.68 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$3.04 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | -$0.31 10-Q · filed 2022-11-09 | -$0.52 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.80 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | -$0.21 10-Q · filed 2022-08-03 | -$0.49 10-Q · filed 2022-08-03 | |||||||
| 2021-03-31 | -$0.29 10-Q · filed 2022-04-27 | ||||||||
| 2015-12-31 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2015-09-30 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2015-06-30 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2015-03-31 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2014-12-31 | -$0.03 10-K · filed 2016-03-16 | ||||||||
| 2014-09-30 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2014-06-30 | -$0.03 10-K · filed 2016-03-16 | ||||||||
| 2014-03-31 | -$0.02 10-K · filed 2016-03-16 | ||||||||
| 2013-12-31 | -$0.04 10-K · filed 2015-03-20 | ||||||||
| 2013-09-30 | -$0.01 10-K · filed 2015-03-20 | ||||||||
| 2013-06-30 | -$0.02 10-K · filed 2015-03-20 | ||||||||
| 2013-03-31 | -$0.03 10-K · filed 2015-03-20 | ||||||||
| 2012-12-31 | -$0.03 10-K · filed 2014-03-14 | ||||||||
| 2012-09-30 | -$0.02 10-K · filed 2014-03-14 | ||||||||
| 2012-06-30 | -$0.03 10-K · filed 2014-03-14 | ||||||||
| 2012-03-31 | -$0.04 10-K · filed 2014-03-14 | ||||||||
| 2011-12-31 | -$0.08 10-K · filed 2013-03-18 | -$0.15 derived: net income ÷ weighted average shares · filed 2014-03-14 | -$2.11 derived: net income ÷ weighted average shares · filed 2012-03-30 | ||||||
| 2011-09-30 | -$0.02 10-K · filed 2013-03-18 | ||||||||
| 2011-06-30 | -$0.01 10-K · filed 2013-03-18 | ||||||||
| 2011-03-31 | -$0.04 10-K · filed 2013-03-18 | ||||||||
| 2010-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2014-03-14 | ||||||||
| 2009-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |